Founding Enterprise AE - AI Pharma SaaS

Basetwo; Oregon; Hybrid; USD 120,000 - 180,000; Full time

Benefits offered by this job

Equity

Performance-based compensation

Direct exposure to founders

Growth opportunities

Job summary

Basetwo is a fast-growing AI startup focused on transforming pharmaceutical manufacturing in North America. We are seeking a founding Life Sciences Enterprise Account Executive to own end-to-end enterprise sales in the US pharma sector and build executive-level relationships with top pharma accounts.

You will prospect, develop pipelines, conduct discovery calls and demos, and close multi-year, high-value contracts.

Qualifications

• Proven enterprise SaaS sales experience in pharma, selling to PD or Manufacturing.
• Track record of building and maintaining executive-level relationships.
• Experience managing long sales cycles and large ACV deals.
• Excellent presentation, negotiation, and written communication skills.
• Willingness to travel up to 25% (US-focused with potential travel to Europe).

Responsibilities

• Own end-to-end enterprise sales in US pharma accounts.
• Build a robust pipeline of net-new enterprise pharma accounts across PD, MSAT, and manufacturing.
• Lead discovery calls, demos, and executive presentations for stakeholders.
• Collaborate with the founding team to develop forecasts and GTM strategy.
• Travel up to 25% within the US, with occasional Europe trips for strategic accounts.
• Maintain accurate records in CRM and report on pipeline and performance.

Skills

Enterprise SaaS sales

Pharma domain knowledge

Executive relationships

Strategic selling

Travel up to 25%

Job description

Basetwo is a fast-growing AI startup focused on transforming pharmaceutical manufacturing in North America. We are seeking a founding Life Sciences Enterprise Account Executive to own end-to-end enterprise sales in the US pharma sector and build executive-level relationships with top pharma accounts.

You will prospect, develop pipelines, conduct discovery calls and demos, and close multi-year, high-value contracts.